Australia markets closed

Adaptive Biotechnologies Corporation (1HM.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
3.4930-0.1120 (-3.11%)
At close: 08:06AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 503.45M
Enterprise value 308.41M
Trailing P/E 43.54
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.26
Price/book (mrq)2.10
Enterprise value/revenue 1.92
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.27
52-week change 3-37.84%
S&P500 52-week change 326.49%
52-week high 38.0860
52-week low 32.2140
50-day moving average 32.8469
200-day moving average 34.0780

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5147.37M
Implied shares outstanding 6147.43M
Float 889.5M
% held by insiders 12.00%
% held by institutions 196.04%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -123.24%
Operating margin (ttm)-116.45%

Management effectiveness

Return on assets (ttm)-17.10%
Return on equity (ttm)-61.58%

Income statement

Revenue (ttm)174.5M
Revenue per share (ttm)1.20
Quarterly revenue growth (yoy)11.20%
Gross profit (ttm)N/A
EBITDA -171.15M
Net income avi to common (ttm)-215.06M
Diluted EPS (ttm)-1.3700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)308.87M
Total cash per share (mrq)2.1
Total debt (mrq)228.04M
Total debt/equity (mrq)82.99%
Current ratio (mrq)4.51
Book value per share (mrq)1.87

Cash flow statement

Operating cash flow (ttm)-135.52M
Levered free cash flow (ttm)-65.73M